Title:
3-(2-AMINO-1-AZACYCLYL)-5-ARYL-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS
Document Type and Number:
WIPO Patent Application WO2004103279
Kind Code:
A3
Abstract:
The present invention encompasses compounds of Formula (I): as well as the pharmaceutically acceptable salts thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
More Like This:
Inventors:
COLANDREA VINCENT J (US)
DOHERTY GEORGE A (US)
HALE JEFFREY J (US)
LYNCH CHRISTOPHER (US)
MILLS SANDER G (US)
NEWAY WILLIAM EDWARD III (US)
TOTH LESLIE (US)
DOHERTY GEORGE A (US)
HALE JEFFREY J (US)
LYNCH CHRISTOPHER (US)
MILLS SANDER G (US)
NEWAY WILLIAM EDWARD III (US)
TOTH LESLIE (US)
Application Number:
PCT/US2004/014837
Publication Date:
May 19, 2005
Filing Date:
May 12, 2004
Export Citation:
Assignee:
MERCK & CO INC (US)
COLANDREA VINCENT J (US)
DOHERTY GEORGE A (US)
HALE JEFFREY J (US)
LYNCH CHRISTOPHER (US)
MILLS SANDER G (US)
NEWAY WILLIAM EDWARD III (US)
TOTH LESLIE (US)
COLANDREA VINCENT J (US)
DOHERTY GEORGE A (US)
HALE JEFFREY J (US)
LYNCH CHRISTOPHER (US)
MILLS SANDER G (US)
NEWAY WILLIAM EDWARD III (US)
TOTH LESLIE (US)
International Classes:
C07D413/04; A61K; (IPC1-7): C07D413/04
Foreign References:
US3647809A | 1972-03-07 |
Other References:
See also references of EP 1625123A4
Download PDF: